HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 324 filers reported holding HALOZYME THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.34 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $81,314 | -32.6% | 2,129,204 | +0.4% | 0.14% | -41.7% |
| Q4 2022 | $120,660 | -99.9% | 2,120,571 | -1.3% | 0.24% | +40.7% |
| Q3 2022 | $84,943,000 | -11.1% | 2,148,273 | -1.1% | 0.17% | -2.8% |
| Q2 2022 | $95,590,000 | +9.7% | 2,172,478 | -0.6% | 0.18% | +52.6% |
| Q1 2022 | $87,149,000 | +12.4% | 2,185,274 | +13.4% | 0.12% | +23.4% |
| Q4 2021 | $77,514,000 | -3.3% | 1,927,738 | -2.1% | 0.09% | -5.1% |
| Q3 2021 | $80,141,000 | -10.6% | 1,970,055 | -0.3% | 0.10% | -9.2% |
| Q2 2021 | $89,693,000 | +8.6% | 1,975,194 | -0.3% | 0.11% | +1.9% |
| Q1 2021 | $82,599,000 | -2.6% | 1,981,256 | -0.2% | 0.11% | -4.5% |
| Q4 2020 | $84,781,000 | +123.0% | 1,985,026 | +37.2% | 0.11% | +103.6% |
| Q3 2020 | $38,024,000 | -0.1% | 1,446,855 | +1.9% | 0.06% | -9.8% |
| Q2 2020 | $38,052,000 | +63.2% | 1,419,336 | +9.5% | 0.06% | +27.1% |
| Q1 2020 | $23,315,000 | +2.1% | 1,296,003 | +0.6% | 0.05% | +23.1% |
| Q4 2019 | $22,835,000 | +13.9% | 1,287,945 | -0.3% | 0.04% | 0.0% |
| Q3 2019 | $20,041,000 | – | 1,292,163 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 19,816,162 | $195,784,000 | 9.33% |
| BB BIOTECH AG | 5,846,564 | $57,764,000 | 2.74% |
| QVT Financial LP | 4,556,090 | $45,014,000 | 2.44% |
| Parametrica Management Ltd | 29,578 | $292,000 | 2.21% |
| SECTORAL ASSET MANAGEMENT INC | 4,389,682 | $43,370,000 | 1.84% |
| Belmont Global Advisors, Inc. | 257,000 | $2,539,000 | 1.83% |
| HARVEY CAPITAL MANAGEMENT INC | 394,550 | $3,898,000 | 1.40% |
| Lombard Odier Asset Management (USA) Corp | 1,350,000 | $13,338,000 | 0.70% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 6,199,685 | $61,253,000 | 0.63% |
| Callan Capital, LLC | 199,230 | $1,968,000 | 0.53% |